Taxpayer-funded Drugs and a Pricing Crisis
This could be a cure for a disease that is devastating and disproportionately impacts marginalized communities.
MEDIA ADVISORY: Patients Implore Congress to Stand Up To Big Pharma
Friday: House Oversight Hearing Examining Devastating Impact of High Prescription Drug Prices on American Families.
The value of a dollar is worth more to pharmaceutical corporations than the value of a life.
There’s a gene therapy coming out that could be like a cure for sickle cell. Costs for this type of medicine for other diseases are running into the millions.
ADVISORY: Cancer Patient David Mitchell to Address National Academy of Medicine Conference on Thursday
Two-Day Workshop Examines NIH’s Role in Drug Development and Pricing.
My body is a battlefield.
It took me about seven years to complete my bachelor's degree due to the setbacks and complications that come with sickle cell.
Sickle cell had literally deteriorated my body.
There are already so many roadblocks to finding care and even qualifying for treatment –– high prices should not be a factor for patients.
Another day is not a guarantee.
At 23 I lost my best friend to this disease and I realized that, for any of us with sickle cell, another day is not a guarantee. I know that when I walk into the ER, I might not walk out.
Taxpayer-Funded Drugs & A Pricing Crisis
This system enables pharmaceutical companies to turn taxpayer investment into unrestrained profit without regard to affordability or accessibility.
